Effectiveness of Nicotine Replacement Therapy on Smoking Cessation and Reduction Among Pulmonary Tuberculosis Patients - A Randomized Controlled Trial

Overview

Journal Int J Prev Med

Date 2023 Jun 23

PMID 37351046

Authors

Jagannath Purushothama

Sanjeev Badiger

Jeby J Olickal

Rahul Kunkulol

Nanjesh Kumar

Neevan Dsouza

Affiliations

Soon will be listed here.

Abstract

Background’: India is ranked second in the world in terms of tobacco use and tops the list of eight high-burden countries that account for two-thirds of the new tuberculosis (TB) cases globally. As tobacco smoking among TB patients is associated with unsuccessful TB treatment outcomes, effective smoking cessation interventions for TB patients is essential to combat this double pandemic.

Aim: The study determined the effectiveness of nicotine replacement therapy (NRT) on smoking reduction and cessation among pulmonary TB patients.

Settings And Design: The study included 300 pulmonary TB patients undergoing antitubercular treatment in government health care centers of Dakshina Kannada district in southern India.

Materials And Methods: The participants in this two-armed, single-blinded, placebo-controlled, block-randomized trial were divided equally ( = 150) for experimental arm (brief advice + NRT) and control arm (brief advice + placebo). The total duration of treatment and follow-up was 6 months. Unadjusted relative risk (URR) and adjusted relative risk (ARR) were calculated for treatment outcomes at 95% confidence interval (CI). Generalized linear regression analysis was performed upon variables with value less than 0.2.

Results: After 6 months of intervention including follow up, there was a significant reduction in self-reported smoking (ARR = 1.08, 95% CI 1.01-1.17, = 0.03) in the experimental arm compared with the control arm. Biochemically verified smoking abstinence was not significantly different between the two arms (ARR = 1.01, 95% CI 0.72-1.38, = 0.97).

Conclusion: The study showed statistically significant effectiveness of NRT for self-reported smoking reduction.

References

Leung C, Yew W, Chan C, Chang K, Law W, Lee S . Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2014; 45(3):738-45. DOI: 10.1183/09031936.00114214. View

Awaisu A, Mohamed M, Mohamad Noordin N, Aziz N, Syed Sulaiman S, Razak Muttalif A . The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy. 2011; 6:26. PMC: 3196696. DOI: 10.1186/1747-597X-6-26. View

Aryanpur M, Hosseini M, Masjedi M, Mortaz E, Tabarsi P, Soori H . A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis. BMC Infect Dis. 2016; 16:369. PMC: 4974814. DOI: 10.1186/s12879-016-1727-4. View

Hersi M, Traversy G, Thombs B, Beck A, Skidmore B, Groulx S . Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review. Syst Rev. 2019; 8(1):28. PMC: 6339342. DOI: 10.1186/s13643-018-0928-x. View

Mahishale V, Patil B, Lolly M, Eti A, Khan S . Prevalence of Smoking and Its Impact on Treatment Outcomes in Newly Diagnosed Pulmonary Tuberculosis Patients: A Hospital-Based Prospective Study. Chonnam Med J. 2015; 51(2):86-90. PMC: 4543154. DOI: 10.4068/cmj.2015.51.2.86. View

Fagerstrom K, Tejding R, Westin A, Lunell E . Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?. Tob Control. 1997; 6(4):311-6. PMC: 1759592. DOI: 10.1136/tc.6.4.311. View

Goel S, Kathiresan J, Singh P, Singh R . Effect of a brief smoking cessation intervention on adult tobacco smokers with pulmonary tuberculosis: A cluster randomized controlled trial from North India. Indian J Public Health. 2017; 61(Suppl 1):S47-S53. DOI: 10.4103/ijph.IJPH_265_17. View

Woolacott N, Jones L, Forbes C, Mather L, Sowden A, Song F . The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess. 2002; 6(16):1-245. DOI: 10.3310/hta6160. View

Lam T, Chan S, Abdullah A, Wong V, Chan A, Hedley A . Smoking reduction intervention for smokers not willing to quit smoking: a randomised controlled trial. Hong Kong Med J. 2012; 18 Suppl 3:4-8. View

10.

Marshall A, Barua D, Mitchell A, Keding A, Huque R, Khan A . Smoking prevalence among tuberculosis patients: A crosssectional study in Bangladesh and Pakistan. Tob Induc Dis. 2020; 18:70. PMC: 7485439. DOI: 10.18332/tid/125452. View

11.

van Zyl Smit R, Pai M, Yew W, Leung C, Zumla A, Bateman E . Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J. 2010; 35(1):27-33. PMC: 5454527. DOI: 10.1183/09031936.00072909. View

12.

Amere G, Nayak P, Salindri A, Narayan K, Magee M . Contribution of Smoking to Tuberculosis Incidence and Mortality in High-Tuberculosis-Burden Countries. Am J Epidemiol. 2018; 187(9):1846-1855. PMC: 6888026. DOI: 10.1093/aje/kwy081. View

13.

Ellerbeck E, Nollen N, Hutcheson T, Phadnis M, Fitzgerald S, Vacek J . Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial. JAMA Netw Open. 2019; 1(5):e181843. PMC: 6324503. DOI: 10.1001/jamanetworkopen.2018.1843. View

14.

Louwagie G, Okuyemi K, Ayo-Yusuf O . Efficacy of brief motivational interviewing on smoking cessation at tuberculosis clinics in Tshwane, South Africa: a randomized controlled trial. Addiction. 2014; 109(11):1942-52. DOI: 10.1111/add.12671. View

15.

Kralikova E, Kozak J, Rasmussen T, Gustavsson G, Le Houezec J . Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health. 2009; 9:433. PMC: 2792228. DOI: 10.1186/1471-2458-9-433. View

16.

Stead L, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K . Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012; 11:CD000146. DOI: 10.1002/14651858.CD000146.pub4. View

17.

Edjoc R, Reid R, Sharma M . The effectiveness of smoking cessation interventions in smokers with cerebrovascular disease: a systematic review. BMJ Open. 2012; 2(6). PMC: 3533053. DOI: 10.1136/bmjopen-2012-002022. View

18.

Papadakis S, Aitken D, Gocan S, Riley D, Laplante M, Bhatnagar-Bost A . A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients. BMJ Open. 2011; 1(2):e000366. PMC: 3225588. DOI: 10.1136/bmjopen-2011-000366. View